SOP - NON-PRESCRIPTION INTRAVENOUS DRUG USE

SOP - Costs of Care

(Section 4.04 of the Transfused and Hemophiliac HCV Plans)

1. Where the Administrator is satisfied that the Approved HCV Infected Person requires care due to one of the Level 6 medical conditions caused by HCV (s.4.01(e)) and that such care was recommended by his/her treating physician, the costs of care may include:

(a) home health care;

(b) nursing care;

(d) respite care;

(e) day care;

(f) cost of nursing home care or of long-term care facility;

(g) palliative care; and

(h) case management and claim preparation.

2. Costs of care shall not include:

(a) costs covered under compensation for loss of services in the home (s. 4.03);

(b) costs covered under compensation for uninsured treatment and medication (s. 4.06);

(d) that portion of the costs of care covered by public or private insurance
(s. 4.04); and

(e) that portion of the costs of care in excess of $50,000 (in 1999 dollars) per calendar year (s. 4.04).

3. The Administrator may in its discretion from time to time require verification from the Approved HCV Infected Person's treating physician that care continues to be required due to one of the Level 6 medical conditions caused by HCV.

4. Personal care for the claimant provided by a relative in the home mentioned in paragraph 1(c) is payable up to a maximum of 20 hours per week, unless otherwise recommended by the treating physician or by an approved care assessment specialist in a written report following an assessment visit at the claimant's home.

5. The costs of care mentioned in paragraph 1 (c) are calculated at $12 per hour indexed from 1999 dollars for care provided before January 1st 2010 and at $20 per hour indexed from 2010 for care provided after January 1st 2010.

Disclaimer

This Standard Operating Procedure is intended to assist the reader with respect to the subject matter and the procedures set forth herein. However, in the event there is any difference or ambiguity between this Standard Operating Procedure and the 1986-1990 Hepatitis C Settlement Agreement such difference or ambiguity will be governed by and will be resolved by the terms of the 1986-1990 Hepatitis C Settlement Agreement.